Blood Lymphocyte Subsets for Early Identification of Non-Remission to TNF Inhibitors in Rheumatoid Arthritis

Background: TNF inhibitors (TNFis) are widely used for the treatment of rheumatoid arthritis (RA), although the response rates to this therapy in patients with RA remains heterogeneous and < 50% achieve remission (REM). Objective: To analyze baseline peripheral blood leukocytes profiles in order...

Descripción completa

Detalles Bibliográficos
Autores principales: Rodríguez-Martín, Eulalia, Nieto-Gañán, Israel, Hernández-Breijo, Borja, Sobrino, Cristina, García-Hoz, Carlota, Bachiller, Javier, Martínez-Feito, Ana, Navarro-Compán, Victoria, Lapuente-Suanzes, Paloma, Bonilla, Gema, Pascual-Salcedo, Dora, Roy, Garbiñe, Jurado, Teresa, Nozal, Pilar, Vázquez-Díaz, Mónica, Balsa, Alejandro, Villar, Luisa M., Plasencia-Rodríguez, Chamaida
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7481468/
https://www.ncbi.nlm.nih.gov/pubmed/32973793
http://dx.doi.org/10.3389/fimmu.2020.01913

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7481468/
https://www.ncbi.nlm.nih.gov/pubmed/32973793
http://dx.doi.org/10.3389/fimmu.2020.01913

Ejemplares similares